WEBSITECHANGES

Website Changes

---

01/10/2013

Musella Foundation Co-Pay Assist Program closed.

---

01/09/2013

"National Cancer Comprehensive Network" adds "alternating electric field therapy" (Novocure) to it`s treatment guidelines for treatment of recurrent glioblastoma

---

01/06/2013

Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.

---

12/30/2012

The Methodist Hospital and Remeditex LLC Work to Develop Brain Tumor Drug

---

12/30/2012

Musella Foundation For Brain Tumor Research & Information, Inc 2012 Highlights

---

12/27/2012

Survival odds increase for brain tumor

---

12/27/2012

Electric field treatment takes aim at brain cancer

---

12/20/2012

Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin/Ran protein complex.

---

12/20/2012

Surgical extent impacts the value of the established prognosticators in glioblastoma patients: a prospective translational study in Asia.

---

12/20/2012

Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.

---

12/20/2012

Brain tumors in raccoons linked to newly discovered virus

---

12/19/2012

Voices Against Brain Cancer Hosts Contest on Facebook to Recognize Brain Cancer Scientists and Social Workers

---

12/16/2012

Musella Foundation Grant Award to Tocagen - Interim Progress Report

---

12/11/2012

IBTA E News December 2012

---

12/05/2012

Peregrine Shows Desperation in Dusting Off Ancient Brain Tumor Drug

---

12/04/2012

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study.

---

12/03/2012

Advancing “Breakthrough” Drug Therapies

---

11/30/2012

Correction: video name is: Bringing Light Please vote!

---

11/30/2012

City MD sues radiologists over tumour, brain damage

---

11/30/2012

RTK inhibition: looking for the right pathways toward a miracle.

---

11/30/2012

Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen.

---

11/30/2012

Swedish Receives $2.5 Million Grant from the Ivy Foundation to Advance Brain Cancer Research

---

11/29/2012

Short film about Tumor Paint! Please vote for it!

---

11/28/2012

The Florida Brain Tumor Association (FBTA) is hosting their yearly conference, " Progress Against Brain Tumors" , Feb. 9, 2013.

---

11/28/2012

`Tumor Paint` Research Of Pediatric Oncologist Jim Olson Featured In Short Film -- A Sundance Festival Semifinalist

---